Megan Blewett is a venture capital investor based in New York, United States.
Is Megan Blewett a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- Healthcare
Contacts
Affiliated funds' portfolios
Investor at Scion Life Sciences
Investor Profile
The listing covers sector Healthcare, and focus areas Biotech, Clinical Trials, Drug Development and Therapeutics. Startups operating in these areas may find Megan Blewett relevant.
Megan Blewett is listed for Pre-Seed and Seed rounds in the database.
The focus and stage tags above are the fastest way to judge whether Megan Blewett is worth approaching.
Frequently asked questions
Who is Megan Blewett?
Megan Blewett is a venture capital investor based in New York, United States, with no investments on file. This page carries what the database holds on that profile: investor type, sectors, focus areas, stages and the firms the profile is attached to.
What does Megan Blewett invest in?
Listed sectors include Healthcare; listed focus areas include Biotech, Clinical Trials, Drug Development and Therapeutics. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Megan Blewett invest at?
The database lists Megan Blewett for Pre-Seed and Seed rounds. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
How do I contact Megan Blewett?
An email address, a phone number and a LinkedIn page are on file for Megan Blewett. The address stays masked on this page and is readable inside RaiseHunt after you create an account.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal
